Episodes 1-15 of 30
Platelet Perspectives: Analysing Phase III Data
Medical Industry FeaturePlatelet Perspectives: Analysing Phase III Data
Assessing Cutaneous Squamous Cell Carcinoma in People of Color
Medical Industry FeatureAssessing Cutaneous Squamous Cell Carcinoma in People of Color
Clinical Decision Making for HER2 Low Metastatic Breast Cancer
Medical Industry FeatureClinical Decision Making for HER2 Low Metastatic Breast Cancer
Treating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Medical Industry FeatureTreating ER+/HER2− ESR1m mBC: EMERALD Subgroup Analyses in Clinical Cancer Research
Gene Therapy for Hemophilia B: Real-World Perspectives from an HCP and Patient
Medical Industry FeatureGene Therapy for Hemophilia B: Real-World Perspectives from an HCP and Patient
Frontline Consolidation in B-ALL: Expert Insights on the Role of Blinatumomab
Medical Industry FeatureFrontline Consolidation in B-ALL: Expert Insights on the Role of Blinatumomab
- advertisement
Asparaginase Therapy in Patients with ALL/LBL
Medical Industry FeatureAsparaginase Therapy in Patients with ALL/LBL
Navigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data
Medical Industry FeatureNavigating a Positive MCED Test and Negative Diagnostic Workup: Real-World Data
Decoding Gene Therapy for Hemophilia B: Expert Insights on Common Myths
Medical Industry FeatureDecoding Gene Therapy for Hemophilia B: Expert Insights on Common Myths
Neoadjuvant Immunotherapy and Radiation Boosts Response in NSCLC
Medical Industry FeatureNeoadjuvant Immunotherapy and Radiation Boosts Response in NSCLC
Examining a Therapeutic Modality for 2L+ mNSCLC
Medical Industry FeatureExamining a Therapeutic Modality for 2L+ mNSCLC
Evaluating First-Line Therapy for Acute
Graft-Versus-Host DiseaseMedical Industry FeatureEvaluating First-Line Therapy for Acute
Graft-Versus-Host Disease- advertisement
Managing the Complexities of Acute Graft-Versus-Host Disease: Current Challenges and Unmet Needs
Medical Industry FeatureManaging the Complexities of Acute Graft-Versus-Host Disease: Current Challenges and Unmet Needs
The CLL Patient Journey: From Diagnosis to Initial Treatment
Medical Industry FeatureThe CLL Patient Journey: From Diagnosis to Initial Treatment
Navigating CLL Treatment: Patient Preferences and Shared Decision-Making
Medical Industry FeatureNavigating CLL Treatment: Patient Preferences and Shared Decision-Making
